Evidence map›Paper›PMID 34355170›Full record

ArticleNeuro-oncology advances

Application of Raman spectroscopy for detection of histologically distinct areas in formalin-fixed paraffin-embedded glioblastoma.

Gilbert Georg Klamminger, Jean-Jacques Gérardy, Finn Jelke, Giulia Mirizzi, Rédouane Slimani, Karoline Klein, Andreas Husch, Frank Hertel, Michel Mittelbronn, Felix B Kleine-Borgmann

Open access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gilbert Georg KlammingerSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
Jean-Jacques GérardyNational Center of Pathology (NCP), Laboratoire national de santé (LNS), Dudelange, Luxembourg.
Finn JelkeSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
Giulia MirizziSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
Rédouane SlimaniDepartment of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
Karoline KleinSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
Andreas HuschLuxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg.
Frank HertelSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
Michel MittelbronnNational Center of Pathology (NCP), Laboratoire national de santé (LNS), Dudelange, Luxembourg.
Felix B Kleine-BorgmannSaarland University Medical Center and Faculty of Medicine, Homburg, Germany.
University of Luxembourg · LUCentre Hospitalier de Luxembourg · LUSaarland University · DELaboratoire National de Santé · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough microscopic assessment is still the diagnostic gold standard in pathology, non-light microscopic methods such as new imaging methods and molecular pathology have considerably contributed to more precise diagnostics. As an upcoming method, Raman spectroscopy (RS) offers a "molecular fingerprint" that could be used to differentiate tissue heterogeneity or diagnostic entities. RS has been successfully applied on fresh and frozen tissue, however more aggressively, chemically treated tissue such as formalin-fixed, paraffin-embedded (FFPE) samples are challenging for RS.

methodsTo address this issue, we examined FFPE samples of morphologically highly heterogeneous glioblastoma (GBM) using RS in order to classify histologically defined GBM areas according to RS spectral properties. We have set up an SVM (support vector machine)-based classifier in a training cohort and corroborated our findings in a validation cohort.

resultsOur trained classifier identified distinct histological areas such as tumor core and necroses in GBM with an overall accuracy of 70.5% based on the spectral properties of RS. With an absolute misclassification of 21 out of 471 Raman measurements, our classifier has the property of precisely distinguishing between normal-appearing brain tissue and necrosis. When verifying the suitability of our classifier system in a second independent dataset, very little overlap between necrosis and normal-appearing brain tissue can be detected.

conclusionThese findings show that histologically highly variable samples such as GBM can be reliably recognized by their spectral properties using RS. As conclusion, we propose that RS may serve useful as a future method in the pathological toolbox.

Indexed as

FFPEglioblastomamachine learningpathologyRaman spectroscopy

Identifiers

PMID34355170
PMCPMC8331050
OpenAlexW3176211673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.